These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23530915)

  • 41. Unpaired Guanosines in the 5' Untranslated Region of HIV-1 RNA Act Synergistically To Mediate Genome Packaging.
    Nikolaitchik OA; Somoulay X; Rawson JMO; Yoo JA; Pathak VK; Hu WS
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.
    Shehu-Xhilaga M; Hill M; Marshall JA; Kappes J; Crowe SM; Mak J
    J Virol; 2002 May; 76(9):4331-40. PubMed ID: 11932399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene.
    Liang C; Rong L; Russell RS; Wainberg MA
    J Virol; 2000 Jul; 74(14):6251-61. PubMed ID: 10864634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.
    Poon DT; Li G; Aldovini A
    J Virol; 1998 Mar; 72(3):1983-93. PubMed ID: 9499052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of distal zinc finger of nucleocapsid protein in genomic RNA dimerization of human immunodeficiency virus type 1; no role for the palindrome crowning the R-U5 hairpin.
    Laughrea M; Shen N; Jetté L; Darlix JL; Kleiman L; Wainberg MA
    Virology; 2001 Mar; 281(1):109-16. PubMed ID: 11222101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
    Accola MA; Strack B; Göttlinger HG
    J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors.
    Wagner R; Graf M; Bieler K; Wolf H; Grunwald T; Foley P; Uberla K
    Hum Gene Ther; 2000 Nov; 11(17):2403-13. PubMed ID: 11096444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adaptive laboratory evolution of stable insect cell lines for improved HIV-Gag VLPs production.
    Fernandes B; Vidigal J; Correia R; Carrondo MJT; Alves PM; Teixeira AP; Roldão A
    J Biotechnol; 2020 Jan; 307():139-147. PubMed ID: 31697977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations in matrix and SP1 repair the packaging specificity of a Human Immunodeficiency Virus Type 1 mutant by reducing the association of Gag with spliced viral RNA.
    Ristic N; Chin MP
    Retrovirology; 2010 Sep; 7():73. PubMed ID: 20825656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Venereo-Sanchez A; Gilbert R; Simoneau M; Caron A; Chahal P; Chen W; Ansorge S; Li X; Henry O; Kamen A
    Vaccine; 2016 Jun; 34(29):3371-80. PubMed ID: 27155499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incorporation of pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-pol.
    Cen S; Niu M; Saadatmand J; Guo F; Huang Y; Nabel GJ; Kleiman L
    J Virol; 2004 Jan; 78(2):1042-9. PubMed ID: 14694138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical and Functional Characterization of Mouse Mammary Tumor Virus Full-Length Pr77
    Chameettachal A; Pillai VN; Ali LM; Pitchai FNN; Ardah MT; Mustafa F; Marquet R; Rizvi TA
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29912170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Helper plasmids for production of HIV-1-derived vectors.
    Fuller M; Anson DS
    Hum Gene Ther; 2001 Nov; 12(17):2081-93. PubMed ID: 11747598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.
    Luban J; Goff SP
    J Virol; 1994 Jun; 68(6):3784-93. PubMed ID: 8189516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding of the human immunodeficiency virus type 1 Gag protein to the viral RNA encapsidation signal in the yeast three-hybrid system.
    Bacharach E; Goff SP
    J Virol; 1998 Aug; 72(8):6944-9. PubMed ID: 9658151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM; Sweet MJ; Ross IL; Hume DA
    J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.
    Lee PP; Linial ML
    J Virol; 1994 Oct; 68(10):6644-54. PubMed ID: 7521919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
    Schwartz S; Felber BK; Pavlakis GN
    J Virol; 1992 Jan; 66(1):150-9. PubMed ID: 1727477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The roles of the human immunodeficiency virus type 1 Pol protein and the primer binding site in the placement of primer tRNA(3Lys) onto viral genomic RNA.
    Liang C; Rong L; Morin N; Cherry E; Huang Y; Kleiman L; Wainberg MA
    J Virol; 1997 Dec; 71(12):9075-86. PubMed ID: 9371564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The HIV-1 Rev/RRE system is required for HIV-1 5' UTR cis elements to augment encapsidation of heterologous RNA into HIV-1 viral particles.
    Cockrell AS; van Praag H; Santistevan N; Ma H; Kafri T
    Retrovirology; 2011 Jun; 8():51. PubMed ID: 21702950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.